31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy.
about
31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.In vivo 31P NMR study of combined hyperthermia and photodynamic therapies of mammary carcinoma in the mouse.High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal modelIncreased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.In vivo magnetic resonance imaging of the effects of photodynamic therapyEarly biochemical responses to photodynamic therapy monitored by NMR spectroscopy.Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy.Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.Effects of Photofrin photodynamic action on mitochondrial respiration and superoxide radical generation.Photosensitizing action of isomeric zinc N-methylpyridylporphyrins in human carcinoma cells.Metabolic effects of photodynamically induced apoptosis in an erythroleukemic cell line. A (31)P NMR spectroscopic study of Victoria-Blue-BO-sensitized TF-1 cells.Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supplyCa(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro
P2860
Q30584774-E8501F07-6542-41B3-8529-CAF8C45F1519Q31135596-87E760DA-E1DD-47F1-A309-0B9F4A3B6E8BQ33303889-9DDB90A6-1474-4EA3-A691-FCEFD839E95BQ35981662-D3719E00-FEB8-4464-AF2A-2DFF55DA5BB3Q35984703-F73EFB47-9C56-4F7E-B97E-855CB494C298Q36139509-CF68BCC6-F3B3-44D3-AFB9-CC6A235D977CQ36313645-CDE4B6F1-6EAE-42C0-919D-A3843F7232C6Q36620143-795EE630-3C2D-4450-842E-4A702C00DD49Q36751891-AA2CA1F7-7AEC-4242-ADDE-E742D0CE586FQ36862387-74DE11B7-CE5B-442D-BE51-A7767271F777Q40301598-687A862F-A94C-4505-A3C7-CA37859CB828Q40896215-B876F842-DC98-4C25-BD60-2CCDC8C21641Q41177935-89CE9176-6557-4706-A184-AC2E0BB0E210Q41944216-07CCD516-6F47-4AD7-A54C-EFE2CAE1D609Q42810191-7466B10A-0C74-45E8-953D-566D90EAA560
P2860
31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@en
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@nl
type
label
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@en
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@nl
prefLabel
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@en
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@nl
P2093
P1476
31P-NMR spectroscopy demonstra ...... ponse to photodynamic therapy.
@en
P2093
P304
P356
10.1016/0006-291X(86)91086-7
P407
P577
1986-10-01T00:00:00Z